| Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression (NCT03606395) | Navitor Pharmaceuticals, Inc. | 2018-06-06 |
| Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma (NCT03514069) | Case Comprehensive Cancer Center | 2018-06-05 |
| A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study (NCT03602300) | Drugs for Neglected Diseases | 2018-06-05 |
| A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer (NCT03597581) | Inspirna, Inc. | 2018-06-05 |
| A Study to Evaluate the Efficacy of Salmon Protein Hydrolysate Powder on Energy Increase and Anti-inflammatory Modulation in Healthy Males and Females (NCT03535571) | Hofseth Biocare ASA | 2018-06-05 |
| 3BNC117 and 10-1074 in ART-treated Individuals (NCT03526848) | Rockefeller University | 2018-06-05 |
| Effects of Exenatide on Motor Function and the Brain (NCT03456687) | University of Florida | 2018-06-05 |
| MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer (NCT03531632) | MacroGenics | 2018-06-04 |
| This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 1015550 Are Taken up in the Body and How Well They Are Tolerated. (NCT03542344) | Boehringer Ingelheim | 2018-06-04 |
| Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer (NCT03412799) | Panbela Therapeutics, Inc. | 2018-06-04 |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas (NCT03600649) | Salarius Pharmaceuticals, LLC | 2018-06-04 |
| A Ph 1 Study of Epanova® in Healthy Chineses (NCT03574142) | AstraZeneca | 2018-06-04 |
| Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1 (NCT03570450) | University Hospital, Grenoble | 2018-06-02 |
| Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu (NCT03789539) | VA Pharma Limited Liability Company | 2018-06-02 |
| Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma (NCT03767725) | Shenzhen Second People's Hospital | 2018-06-02 |
| Gentamicin for Junctional Epidermolysis Bullosa (NCT03526159) | University of Southern California | 2018-06-01 |
| Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer (NCT03277482) | Dana-Farber Cancer Institute | 2018-06-01 |
| The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy (NCT04670107) | The Affiliated Hospital of Qingdao University | 2018-06-01 |
| Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD). (NCT03684122) | University of Jordan | 2018-06-01 |
| A Study of LY3314814 in Participants With Liver Impairment (NCT03499041) | Eli Lilly and Company | 2018-06-01 |
| Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells (NCT03575299) | Zhinan Yin, Ph.D. | 2018-06-01 |
| CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer (NCT03370159) | Wake Forest University Health Sciences | 2018-06-01 |
| A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive (NCT03506399) | Eli Lilly and Company | 2018-06-01 |
| A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile (NCT03416335) | Sumitomo Pharma America, Inc. | 2018-06-01 |
| Genetic Variation in Organic Cation Transport 1 (OCT1) and Its Significance for Morphine Pharmacokinetics (NCT03425084) | University of Southern Denmark | 2018-06-01 |
| CART19 Cells Treatment of MRD of B Cell Malignancies and Then Auto-HSCT (NCT03685786) | Shenzhen Second People's Hospital | 2018-06-01 |
| A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants (NCT03545087) | Eli Lilly and Company | 2018-06-01 |
| Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation (NCT03576716) | University of Washington | 2018-06-01 |
| Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Carcinoma (NCT03430687) | University of California, San Francisco | 2018-06-01 |
| SHIFT: Studying HIV Immunology After Fecal Transplant (NCT03163784) | Massachusetts General Hospital | 2018-06-01 |
| A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis (NCT02671188) | GlaxoSmithKline | 2018-06-01 |
| Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells to Non-healing Diabetic Foot Wounds (NCT03509870) | Steno Diabetes Center Copenhagen | 2018-06-01 |
| Comparative Study of PK and BE of VM-1500FDC (Fixed-dose Combination) and Elpida® With Truvada® сo-administrated 1 Daily Fasting in Healthy Subjects (NCT03706924) | Viriom | 2018-06-01 |
| Microbiota Modification for the Treatment of Motor Complication of Parkinson´s Disease (NCT04730245) | Torre Médica Santé | 2018-06-01 |
| Study in Patients With Tumours Requiring Arginine to Assess ADI-PEG 20 With Atezolizumab, Pemetrexed and Carboplatin (NCT03498222) | Queen Mary University of London | 2018-06-01 |
| Effect of Camel Milk With Probiotic on Type 2 Diabetes Mellitus (NCT04296825) | China Agricultural University | 2018-06-01 |
| Study of Sirolimus in Patients With Advanced Pancreatic Cancer (NCT03662412) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-06-01 |
| Study on the Safety and Pharmacokinetics of LM001 and Gonal-F® in Healthy Women (NCT03535103) | Alphamab Jilin Co., Ltd. | 2018-06-01 |
| Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis (NCT03424629) | Tianjin Ever Union Biotechnology Co., Ltd. | 2018-06-01 |
| An Investigational Study to Evaluate the Effect of Rifampin on the Singe Dose of Experimental Medication BMS-986224 in Healthy Participants (NCT03563950) | Bristol-Myers Squibb | 2018-06-01 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-64232025 in Healthy Participants (NCT03550950) | Janssen Research & Development, LLC | 2018-06-01 |
| Anti-Secretory Drug in Treatment of Acute Watery Diarrhea (NCT05216822) | Assiut University | 2018-06-01 |
| The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol (NCT03164512) | Johns Hopkins University | 2018-06-01 |
| Can we Transfuse Blood Over Shorter Period ? (NCT03444610) | King Faisal Specialist Hospital & Research Center | 2018-05-31 |
| Autologous Gene Therapy for Artemis-Deficient SCID (NCT03538899) | University of California, San Francisco | 2018-05-31 |
| A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML (NCT03547115) | MEI Pharma, Inc. | 2018-05-31 |
| A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy Participants (NCT05468164) | Eli Lilly and Company | 2018-05-31 |
| Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease (NCT03327857) | AltruBio Inc. | 2018-05-31 |
| A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions (NCT03573622) | Daewoong Pharmaceutical Co. LTD. | 2018-05-31 |
| Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects (NCT03657550) | Conjupro Biotherapeutics, Inc. | 2018-05-31 |
| A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions (NCT03574285) | Daewoong Pharmaceutical Co. LTD. | 2018-05-31 |
| INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) (NCT03491683) | Inovio Pharmaceuticals | 2018-05-31 |
| Video Distraction to Decrease Use of Sedation in Pediatric Participants During Radiation Therapy (NCT03677531) | OHSU Knight Cancer Institute | 2018-05-31 |
| PF-04995274 and Emotional Processing in Treatment Resistant Depression (NCT03515733) | University of Oxford | 2018-05-31 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese Participants (NCT03536325) | Janssen Pharmaceutical K.K. | 2018-05-31 |
| A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis. (NCT03540524) | Lakefront Biotherapeutics NV | 2018-05-31 |
| Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma (NCT03484299) | University of Louisville | 2018-05-30 |
| Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM (NCT03283631) | Gary Archer Ph.D. | 2018-05-30 |
| An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects (NCT03541564) | Bristol-Myers Squibb | 2018-05-30 |
| Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects (NCT03329573) | GlaxoSmithKline | 2018-05-30 |
| Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease (NCT03522129) | Cognition Therapeutics | 2018-05-30 |
| A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT03441555) | AbbVie | 2018-05-30 |
| Buspirone for Opioid Tapering (NCT03521960) | Johns Hopkins University | 2018-05-30 |
| Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects (NCT03453060) | Aronora, Inc. | 2018-05-30 |
| M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer (NCT03579472) | M.D. Anderson Cancer Center | 2018-05-30 |
| Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma (NCT03161223) | University of Virginia | 2018-05-30 |
| Safety and Pharmacokinetics of Zanubrutinib (BGB-3111) in Healthy Subjects and Those With Impaired Liver Function (NCT03465059) | BeiGene | 2018-05-30 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female Participants (NCT03501069) | Millennium Pharmaceuticals, Inc. | 2018-05-30 |
| An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread (NCT03459222) | Bristol-Myers Squibb | 2018-05-30 |
| Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors (NCT03030378) | National Cancer Institute (NCI) | 2018-05-30 |
| Oral Abuse Potential Study of Nalbuphine (NCT04018664) | Trevi Therapeutics | 2018-05-29 |
| Single Dose of Lu AF28996 to Healthy Young Men (NCT03565094) | H. Lundbeck A/S | 2018-05-29 |
| Study of EOC317 in Chinese Patients With Advanced Solid Tumors (NCT03583125) | Taizhou EOC Pharma Co., Ltd. | 2018-05-29 |
| Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer (NCT03490292) | University of Wisconsin, Madison | 2018-05-29 |
| Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers (NCT03345784) | National Cancer Institute (NCI) | 2018-05-29 |
| AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer (NCT03371485) | Cancer Research UK | 2018-05-29 |
| Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients (NCT03535168) | Bayer | 2018-05-29 |
| Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma (NCT03267888) | Emory University | 2018-05-29 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058 (NCT03708146) | Bial - Portela C S.A. | 2018-05-28 |
| Safety, Tolerability, PK and PD of SAD or MAD of APX-115 in Healthy Male Volunteers (NCT03694041) | Aptabio Therapeutics, Inc. | 2018-05-28 |
| Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802 (NCT03532854) | LG Chem | 2018-05-28 |
| BN201 SAD MAD Study in Healthy Subjects (NCT03630497) | Accure Therapeutics | 2018-05-27 |
| A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian Participants (NCT03501277) | Takeda | 2018-05-26 |
| Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer (NCT03545711) | Chinese Academy of Medical Sciences | 2018-05-26 |
| Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS (NCT03187288) | University Health Network, Toronto | 2018-05-25 |
| QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine (NCT03563170) | ImmunityBio, Inc. | 2018-05-25 |
| An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function (NCT03515980) | Bristol-Myers Squibb | 2018-05-25 |
| Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology (NCT04046614) | AIO-Studien-gGmbH | 2018-05-25 |
| Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers (NCT03671941) | Chong Kun Dang Pharmaceutical | 2018-05-25 |
| Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation (NCT03533101) | Hospital Universitario Dr. Jose E. Gonzalez | 2018-05-25 |
| Gastric Gluten-Degradation Activity of PvP001 (NCT03594331) | Danielle Kim Turgeon | 2018-05-25 |
| A Study Of The Selective PKC-β Inhibitor MS- 553 (NCT03492125) | MingSight Pharmaceuticals, Inc | 2018-05-25 |
| FID-007 in Treating Participants With Advanced Solid Tumors (NCT03537690) | University of Southern California | 2018-05-25 |
| A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin. (NCT03628079) | Repos Pharma | 2018-05-25 |
| A Study to Evaluate the Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability of AG-348 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348 (NCT03703505) | Agios Pharmaceuticals, Inc. | 2018-05-24 |
| Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects (NCT04101370) | Geropharm | 2018-05-24 |
| INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma (NCT03502785) | Inovio Pharmaceuticals | 2018-05-24 |
| Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma (NCT02914405) | University Hospital Southampton NHS Foundation Trust | 2018-05-24 |
| 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer (NCT03490838) | Advanced Accelerator Applications | 2018-05-24 |
| SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors (NCT03604679) | SymBio Pharmaceuticals | 2018-05-24 |